Legal Opinion
Fed. Trade Comm'n v. Shire Viropharma, Inc.
Court of Appeals for the Third Circuit
Decided February 25, 2019No. 18-1807PublishedCited by 36 opinions
1Opinion of the Court
SMITH, Chief Judge.
Shire ViroPharma, Inc. ("Shire"), 1 manufactured and marketed the lucrative drug Vancocin, which is indicated to treat a life-threatening gastrointestinal infection. After Shire got wind that manufacturers were considering making generic equivalents to Vancocin, it inundated the United States Food and Drug Administration ("FDA") with allegedly meritless filings to delay approval of those generics. The FDA eventually rejected Shire's filings and approved generic equivalents to Vancocin, but the filings nonetheless resulted in a high cost to consumers-Shire had delayed…
2Cases cited14 opinions
- Arbaugh v. Y & H Corp.Supreme Court of the United States · 2006
- United States v. W. T. Grant Co.Supreme Court of the United States · 1953
- Verizon Maryland Inc. v. Public Service Commission of MarylandSupreme Court of the United States · 2002
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- Touche Ross & Co. v. RedingtonSupreme Court of the United States · 1979
9 more not listed; retrieve them via the Exa API.
3Cited by36 opinions
- Federal Trade Commission v. AbbVie IncCourt of Appeals for the Third Circuit · 2020
- In re: Suboxone Antitrust v.Court of Appeals for the Third Circuit · 2020
- SEC v. Guy GentileCourt of Appeals for the Third Circuit · 2019
- Oddo v. Bimbo Bakeries U.S.A., Inc.District Court, E.D. Pennsylvania · 2019
- Edward Leo v. Nationstar Mortgage LLC of DelCourt of Appeals for the Third Circuit · 2020
31 more not listed; retrieve them via the Exa API.